secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001822479-25-000022
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q1 net loss $13M includes $31M EO settlement; Adj EBITDA up 8.8%
------------------------------------------------------------------------------

- Net revenues $255M, up 2.6% YoY (4.4% constant currency). Sterigenics segment $170M.
- Net loss $13M ($0.05 diluted loss) vs net income $6M ($0.02) in Q1 2024; includes $31M EO settlement charge.
- Adjusted EBITDA $122M, up 8.8% (11.2% constant currency). Adjusted EPS $0.14 vs $0.13.
- Company reaffirms FY2025 constant-currency outlook: 4-6% net revenue growth, 4.5-6.5% Adj EBITDA growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000022/0001822479-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000022/shc-20250501.htm
  HTML page:      https://secwatch.observer/filing/0001822479-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer